MX2010011232A - Membrana. - Google Patents
Membrana.Info
- Publication number
- MX2010011232A MX2010011232A MX2010011232A MX2010011232A MX2010011232A MX 2010011232 A MX2010011232 A MX 2010011232A MX 2010011232 A MX2010011232 A MX 2010011232A MX 2010011232 A MX2010011232 A MX 2010011232A MX 2010011232 A MX2010011232 A MX 2010011232A
- Authority
- MX
- Mexico
- Prior art keywords
- membrane
- cells
- accordance
- vindication
- hesc
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 64
- 239000011148 porous material Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 7
- -1 polyoxymethylene Polymers 0.000 claims description 6
- 230000012010 growth Effects 0.000 claims description 4
- 238000010899 nucleation Methods 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 230000002207 retinal effect Effects 0.000 claims description 4
- 229930040373 Paraformaldehyde Natural products 0.000 claims 1
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 229920006324 polyoxymethylene Polymers 0.000 claims 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 206010064930 age-related macular degeneration Diseases 0.000 abstract description 3
- 208000002780 macular degeneration Diseases 0.000 abstract description 3
- 238000011282 treatment Methods 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 69
- 210000004379 membrane Anatomy 0.000 description 39
- 239000002609 medium Substances 0.000 description 11
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 6
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 4
- 210000001671 embryonic stem cell Anatomy 0.000 description 4
- 108010057670 laminin 1 Proteins 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102100035914 S-adenosylmethionine decarboxylase proenzyme Human genes 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 108091008695 photoreceptors Proteins 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- NYPYHUZRZVSYKL-UHFFFAOYSA-N 2-azaniumyl-3-(4-hydroxy-3,5-diiodophenyl)propanoate Chemical compound OC(=O)C(N)CC1=CC(I)=C(O)C(I)=C1 NYPYHUZRZVSYKL-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 241001462977 Elina Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 1
- 101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 description 1
- 101000873502 Homo sapiens S-adenosylmethionine decarboxylase proenzyme Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 208000035719 Maculopathy Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004425 Makrolon Substances 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241001510071 Pyrrhocoridae Species 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- 102100031176 Retinoid isomerohydrolase Human genes 0.000 description 1
- 102100040756 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000027073 Stargardt disease Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 241001440802 Ugia Species 0.000 description 1
- 108010006886 Vitrogen Proteins 0.000 description 1
- 208000000208 Wet Macular Degeneration Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 206010001902 amaurosis Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001775 bruch membrane Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940063123 diflucan Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000011120 plywood Substances 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000003763 resistance to breakage Effects 0.000 description 1
- 150000003726 retinal derivatives Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0806746.4A GB0806746D0 (en) | 2008-04-14 | 2008-04-14 | Membrane |
| PCT/GB2009/000917 WO2009127809A1 (en) | 2008-04-14 | 2009-04-08 | Membrane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010011232A true MX2010011232A (es) | 2011-02-23 |
Family
ID=39433610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010011232A MX2010011232A (es) | 2008-04-14 | 2009-04-08 | Membrana. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8642072B2 (https=) |
| EP (1) | EP2265711B1 (https=) |
| JP (1) | JP5552478B2 (https=) |
| KR (2) | KR101317094B1 (https=) |
| CN (1) | CN102016009B (https=) |
| AU (1) | AU2009237462B2 (https=) |
| BR (1) | BRPI0910936A2 (https=) |
| CA (1) | CA2720264C (https=) |
| CO (1) | CO6311115A2 (https=) |
| DK (1) | DK2265711T3 (https=) |
| ES (1) | ES2665284T3 (https=) |
| GB (1) | GB0806746D0 (https=) |
| IL (1) | IL208745A (https=) |
| MX (1) | MX2010011232A (https=) |
| MY (1) | MY159049A (https=) |
| NZ (1) | NZ587753A (https=) |
| RU (1) | RU2530169C2 (https=) |
| WO (1) | WO2009127809A1 (https=) |
| ZA (1) | ZA201006326B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110112101A1 (en) * | 2009-03-05 | 2011-05-12 | Sanofi-Aventis | Treatment for ocular-related disorders |
| ES2750028T3 (es) * | 2010-05-10 | 2020-03-24 | Tsutomu Yasukawa | Método de producción de una lámina celular |
| AU2011279250B2 (en) | 2010-07-12 | 2014-12-04 | California Institute Of Technology | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
| CN103459593A (zh) * | 2011-02-25 | 2013-12-18 | 独立行政法人理化学研究所 | 视网膜色素上皮细胞片层的生产方法 |
| US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
| US10478206B2 (en) | 2011-04-29 | 2019-11-19 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
| WO2012177968A1 (en) * | 2011-06-22 | 2012-12-27 | The Schepens Eye Research Institute, Inc. | A scaffold for subretinal cell transplantation and drug delivery |
| KR101970846B1 (ko) * | 2011-07-11 | 2019-08-13 | 이어 사이언스 인스티튜트 오스트레일리아 | 이어 드럼 복원용 장치 |
| CN103007355B (zh) * | 2011-09-20 | 2014-08-13 | 同济大学 | 一种水凝胶-纳米纤维膜及其制备方法和用途 |
| CA2792081C (en) * | 2011-10-11 | 2020-10-27 | Bond University Ltd | Layered compositions comprising 3d nanofibre webbing for tissue repair |
| TWI719277B (zh) | 2011-11-14 | 2021-02-21 | 美商安斯泰來再生醫藥協會 | 人類rpe細胞之醫藥組合物及其用途 |
| US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
| US20130330825A1 (en) * | 2012-06-07 | 2013-12-12 | City Of Hope | Attachment substrates for directed differentiation of human embryonic stem cells in culture |
| BR112015003839B1 (pt) | 2012-08-24 | 2021-12-28 | Riken | Método para produzir lâmina de células do epitélio pigmentar da retina |
| RU2518972C1 (ru) * | 2012-12-24 | 2014-06-10 | Общество с ограниченной ответственностью "НАНО КАСКАД" | Трековая мембрана для фильтрации крови |
| CA2933083A1 (en) | 2013-12-11 | 2015-06-18 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
| CN105013010B (zh) * | 2015-07-07 | 2018-01-12 | 中山大学中山眼科中心 | 一种辅助iPS‑RPE移植的层粘连蛋白膜 |
| CN105597145A (zh) * | 2016-02-22 | 2016-05-25 | 中山大学中山眼科中心 | 一种视网膜细胞支架生物手术粘合剂及其制备方法 |
| WO2018003858A1 (ja) * | 2016-06-28 | 2018-01-04 | 国立研究開発法人農業・食品産業技術総合研究機構 | 細胞封入用デバイス及びその使用 |
| EP3843798A1 (en) | 2018-08-31 | 2021-07-07 | Wisconsin Alumni Research Foundation | Generating arterial endothelial cell-seeded vascular grafts |
| AU2020260894B2 (en) * | 2019-04-26 | 2025-06-05 | Racthera Co., Ltd. | Composite including neural retina, retinal pigment epithelial cells, and hydrogel, and method for producing same |
| RU2704094C1 (ru) * | 2019-05-16 | 2019-10-23 | федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ трансплантации ретинального пигментного эпителия в форме многоклеточных 3D сфероидов в эксперименте |
| JP2021141877A (ja) * | 2020-03-13 | 2021-09-24 | 大日本印刷株式会社 | 細胞培養基材、細胞付細胞培養基材、細胞培養容器、細胞付細胞培養容器、上皮細胞シート及びその製造方法、被験物質の評価方法並びに評価キット |
| JP7676135B2 (ja) * | 2020-12-14 | 2025-05-14 | 日本バイリーン株式会社 | 細胞培養担体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0118984D0 (en) * | 2001-08-03 | 2001-09-26 | Intercytex Ltd | Fusion of cells |
| CN1739813A (zh) * | 2005-09-15 | 2006-03-01 | 上海赐人合元企业发展有限公司 | 组织工程表皮替代物及其制备方法 |
| KR100901343B1 (ko) | 2007-07-23 | 2009-06-05 | (주)실리콘화일 | 결정질 반도체 박막 제조 방법 |
| RU2368359C1 (ru) * | 2008-07-22 | 2009-09-27 | Государственное учреждение "УФИМСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ" Академии наук Республики Башкортостан (УфНИИ ГБ АН РБ) | Способ лечения возрастной макулярной дегенерации |
-
2008
- 2008-04-14 GB GBGB0806746.4A patent/GB0806746D0/en not_active Ceased
-
2009
- 2009-04-08 JP JP2011504521A patent/JP5552478B2/ja active Active
- 2009-04-08 EP EP09732279.6A patent/EP2265711B1/en active Active
- 2009-04-08 MY MYPI2010004529A patent/MY159049A/en unknown
- 2009-04-08 US US12/933,694 patent/US8642072B2/en active Active
- 2009-04-08 CA CA2720264A patent/CA2720264C/en active Active
- 2009-04-08 ES ES09732279.6T patent/ES2665284T3/es active Active
- 2009-04-08 RU RU2010144399/10A patent/RU2530169C2/ru not_active IP Right Cessation
- 2009-04-08 WO PCT/GB2009/000917 patent/WO2009127809A1/en not_active Ceased
- 2009-04-08 KR KR1020107022953A patent/KR101317094B1/ko not_active Expired - Fee Related
- 2009-04-08 MX MX2010011232A patent/MX2010011232A/es active IP Right Grant
- 2009-04-08 BR BRPI0910936A patent/BRPI0910936A2/pt not_active Application Discontinuation
- 2009-04-08 KR KR1020137014211A patent/KR20130065737A/ko not_active Ceased
- 2009-04-08 CN CN200980113395.3A patent/CN102016009B/zh active Active
- 2009-04-08 AU AU2009237462A patent/AU2009237462B2/en active Active
- 2009-04-08 DK DK09732279.6T patent/DK2265711T3/en active
- 2009-04-08 NZ NZ587753A patent/NZ587753A/en unknown
-
2010
- 2010-09-03 ZA ZA2010/06326A patent/ZA201006326B/en unknown
- 2010-10-14 IL IL208745A patent/IL208745A/en not_active IP Right Cessation
- 2010-11-12 CO CO10142317A patent/CO6311115A2/es active IP Right Grant
-
2014
- 2014-01-03 US US14/146,744 patent/US8889179B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MY159049A (en) | 2016-12-15 |
| AU2009237462B2 (en) | 2012-12-20 |
| IL208745A (en) | 2015-04-30 |
| KR20100128329A (ko) | 2010-12-07 |
| WO2009127809A1 (en) | 2009-10-22 |
| RU2530169C2 (ru) | 2014-10-10 |
| BRPI0910936A2 (pt) | 2015-10-06 |
| RU2010144399A (ru) | 2012-05-20 |
| US8642072B2 (en) | 2014-02-04 |
| JP2011517696A (ja) | 2011-06-16 |
| ES2665284T3 (es) | 2018-04-25 |
| KR20130065737A (ko) | 2013-06-19 |
| EP2265711A1 (en) | 2010-12-29 |
| KR101317094B1 (ko) | 2013-10-16 |
| CN102016009A (zh) | 2011-04-13 |
| US8889179B2 (en) | 2014-11-18 |
| DK2265711T3 (en) | 2018-04-30 |
| GB0806746D0 (en) | 2008-05-14 |
| ZA201006326B (en) | 2011-09-28 |
| AU2009237462A1 (en) | 2009-10-22 |
| CA2720264A1 (en) | 2009-10-22 |
| EP2265711B1 (en) | 2018-03-07 |
| CN102016009B (zh) | 2015-05-20 |
| JP5552478B2 (ja) | 2014-07-16 |
| IL208745A0 (en) | 2010-12-30 |
| US20110236464A1 (en) | 2011-09-29 |
| US20140127282A1 (en) | 2014-05-08 |
| NZ587753A (en) | 2012-07-27 |
| CO6311115A2 (es) | 2011-08-22 |
| CA2720264C (en) | 2016-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010011232A (es) | Membrana. | |
| Madden et al. | Human corneal endothelial cell growth on a silk fibroin membrane | |
| JP6140240B2 (ja) | 組織工学的に作製された絹製臓器 | |
| JP5908664B2 (ja) | ポリマーコーティング及び細胞接着方法 | |
| JP4335873B2 (ja) | 再生角膜内皮細胞シート、製造方法及びその利用方法 | |
| KR101575226B1 (ko) | 폴리도파민이 결합된 생리활성 펩타이드로 고정화된 고분자 지지체 및 이의 제조방법 | |
| de la Mata et al. | Poly-l/dl-lactic acid films functionalized with collagen IV as carrier substrata for corneal epithelial stem cells | |
| Kirby et al. | Cell sheets in cell therapies | |
| JP2006320304A (ja) | 密閉系細胞培養容器及びそれを利用した細胞培養方法 | |
| KR20200106713A (ko) | 세포특이적 부착능을 증강시키는 폴리비닐 알코올 나노섬유 멤브레인 제조 방법 | |
| Sipehia et al. | Towards an artificial cornea: surface modifications of optically clear, oxygen permeable soft contact lens materials by ammonia plasma modification technique for the enhanced attachment and growth of corneal epithelial cells | |
| JP5252828B2 (ja) | 上皮系細胞培養方法 | |
| Serrano et al. | A Nd: YAG laser-microperforated poly (3-hydroxybutyrate-co-3-hydroxyvalerate)-basal membrane matrix composite film as substrate for keratinocytes | |
| TWI909643B (zh) | 高通量三維細胞球體培養板及其製備方法與應用 | |
| US20250367347A1 (en) | Fibrin patch containing corneal epithelial cells and the method of manufacturing thereof | |
| Ramesh et al. | A bioengineered sequentially layered in vitro corneal construct | |
| US20250318518A1 (en) | Cell-seeded substrates and related materials and methods | |
| RU2464987C1 (ru) | Способ получения резорбируемой полилактидной матрицы для культивирования и имплантации клеток, предназначенных для заживления ран | |
| TWI693283B (zh) | 一種微細胞層片的製造方法 | |
| HK1146092A (en) | Membrane | |
| HK1146092B (en) | Membrane | |
| Li et al. | Cultivation of periodontal tissue cell sheet by a new way for cell sheet engineering | |
| WO2022254961A1 (ja) | 幹細胞を作製するための細胞培養補助剤、及び幹細胞の作製方法 | |
| TWI438277B (zh) | 神經移植體 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |